Patton Fund Management, Inc. Dexcom Inc Transaction History

Patton Fund Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 31, 2023	SELL	$86.06 - $137.93 $942,787 - $1.51 Million	-10,955 Reduced 39.9%	16,499 $1.54 Million
Q2 2023 Jul 12, 2023	BUY	$112.47 - $130.98 $3.09 Million - $3.6 Million	27,454 New	27,454 $3.53 Million
Q4 2020 Jan 29, 2021	SELL	$78.0 - $104.5 $338,910 - $454,052	-4,345 Closed	0 $0
Q3 2020 Oct 20, 2020	BUY	$95.51 - $112.95 $414,990 - $490,767	4,345 New	4,345 $1.79 Million

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.9B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Patton Fund Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Patton Fund Management, Inc. with notifications on news.